489 F.Supp.2d 230 (E.D.N.Y. 2007), 04-MD-1596, In re Zyprexa Products Liability Litigation
Linked as:
Extract
489 F.Supp.2d 230 (E.D.N.Y. 2007), 04-MD-1596, In re Zyprexa Products Liability Litigation
No longer available (Autolink)
See the full content of this document
This document cites
- Code of Federal Regulations - Advisory opinions
- Code of Federal Regulations - Requirements on content and format of labeling for human prescription drug and biological products
- US Code - 18 U.S.C. § 3592 Mitigating and Aggravating Factors to Be Considered In Determining Whether a Sentence of Death Is Justified
- US Code - 21 U.S.C. § 301 Short Title
- US Code - 21 U.S.C. § 352 Misbranded Drugs and Devices
